Frontier Biotechnologies

Frontier Biotechnologies FCF per Share

The Free Cash Flow per Share of Frontier Biotechnologies (688221.SS) as of Oct 17, 2026 is -0.68 CNY. In the previous year, Free Cash Flow per Share was -0.51 CNY — a change of 34.19% (lower).

FCF per Share

-0.68CNY

YoY

34.19%

Last updated:

Free Cash Flow per Share of Frontier Biotechnologies is 2025 -0.68 CNY. Free Cash Flow per Share of Frontier Biotechnologies was 2024 -0.51 CNY. It decreases by 34.19% lower compared to the previous year.

The Frontier Biotechnologies FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-0.48 CNY
Jan 1, 2019
-0.34 CNY
Jan 1, 2020
-0.95 CNY
Jan 1, 2021
-1.52 CNY
Jan 1, 2022
-1.15 CNY
Jan 1, 2023
-1.06 CNY
Jan 1, 2024
-0.51 CNY
Jan 1, 2025
-0.68 CNY
The Frontier Biotechnologies FCF per Share history
YEARFCF per ShareYoY
-0.68CNY+34.19%
-0.51CNY-51.80%
-1.06CNY-7.66%
-1.15CNY-24.69%
-1.52CNY+59.91%
-0.95CNY+182.53%
-0.34CNY-30.19%
-0.48CNY+7.27%
-0.45CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Frontier Biotechnologies Stock analysis

What does Frontier Biotechnologies do? Frontier Biotechnologies Inc is a biotechnology company headquartered in Nanjing, China. It focuses on research, development, production, and sale of medicines. The company has 495 employees and completed its IPO on October 28, 2020. Its products include Aikening and a combination regimen of Albuvirtide (ABT) plus 3BNC117 for HIV treatment, currently in clinical stages. Another clinical-stage product is the transdermal analgesic patch AB001 for muscle, skeleton, and joint pain. The company operates in both domestic and overseas markets. Frontier Biotechnologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Frontier Biotechnologies stock

Free Cash Flow per Share of Frontier Biotechnologies is -0.68 CNY in 2025.

Free Cash Flow per Share of Frontier Biotechnologies changed from -0.51 CNY to -0.68 CNY, representing a 34.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Frontier Biotechnologies since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Frontier Biotechnologies

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Frontier Biotechnologies